Episode
Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances
- Podcast
- Hematologic Oncology Update
- Published
- Aug 17, 2026
- Duration seconds
- 3465
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/multiple-myeloma-year-in-review-series-on-relevant-new-datasets-and-advances/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/hematologic-oncology-update-916423/multiple-myeloma-year-in-review-series-on-relevant-new-datasets-and-advances.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Featuring perspectives from Dr Amrita Krishnan and Dr Robert Z Orlowski, including the following topics: Introduction (00:00) Up-Front Progression-Free Survival for Standard-Risk Disease — 2006, 2016 (1:47) Current and Emerging Therapeutic Approaches — Dr Orlowski (10:34) Chimeric Antigen Receptor T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates — Dr Krishnan (27:15) ASCO and EHA 2026 (46:37) CME information and select publications